文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

危重症患者急性期与恢复期口咽吞咽障碍患病率及特征的系统评价

A Systematic Review of the Prevalence and Characteristics of Oropharyngeal Dysphagia in Critically Ill Patients During the Acute and Postacute Recovery Phase.
PubMed 文献 · Crit Care Med · 2025-03-27
一句话结论系统评价显示危重症成人吞咽障碍患病率15%–100%,出院时最高达74%,出院后10–17个月仍可达22%,但证据受研究设计限制无法得出确定结论。

该系统评价注册于PROSPERO并遵循PRISMA指南,检索5个数据库(PubMed、Scopus、Cochrane Library、CINAHL、Embase)自建库至2024年9月,纳入51篇符合标准的文献,研究对象为18岁以上诊断COVID-19、脓毒症、危重症或重症后综合征并接受临床吞咽评估的成人,场景为急性期或恢复期。结果显示吞咽障碍患病率范围为15%–100%,出院时持续存在者高达74%,出院后10–17个月仍高达22%。作者指出由于研究设计局限、高偏倚风险及方法学/结局异质性,无法得出确定结论,但现有数据提示危重症成人吞咽障碍患病率高且可持续≥12个月,鉴于隐性误吸发生率高,需要前瞻性纵向研究进一步了解慢性吞咽障碍对健康和生活质量的影响。

要点

  • 危重症成人吞咽障碍患病率范围15%–100%,出院时持续存在者高达74%。
  • 出院后10–17个月仍有高达22%的患者存在吞咽障碍,提示问题可持续≥12个月。
  • 纳入研究存在设计局限、高偏倚风险及方法学/结局异质性,无法得出确定结论。
  • 作者指出隐性误吸发生率高,需前瞻性纵向研究了解慢性吞咽障碍对健康和生活质量的影响。

适用人群与场景

  • 年龄大于18岁的成人,诊断为COVID-19、脓毒症、危重症或重症后综合征并存在吞咽障碍,接受临床吞咽评估,处于急性期或恢复期医疗场景。

诊断标准与关键阈值

  • 纳入标准:1)年龄大于18岁;2)诊断为COVID-19、脓毒症、危重症或重症后综合征并存在吞咽障碍;3)接受临床吞咽评估;4)处于急性期或恢复期医疗场景。

红旗征与不能漏的情况

  • 作者指出隐性误吸发生率高。

研究设计与关键结果

  • 系统评价注册于PROSPERO并遵循PRISMA指南,检索PubMed、Scopus、Cochrane Library、CINAHL和Embase五个数据库自建库至2024年9月,检索词包括dysphagia、deglutition disorders、swallowing disorders、sepsis、postintensive care syndrome、COVID-19、critical illness。
  • 去重后识别5058篇文章,基于标题/摘要筛除4844篇,对214篇进行全文审查,最终51篇符合纳入标准。
  • 吞咽障碍患病率范围为15%–100%。
  • 出院时吞咽障碍持续存在者高达74%,出院后10–17个月高达22%。

证据类型、等级与局限

  • 证据类型:系统评价,注册于PROSPERO,遵循PRISMA指南,采用牛津循证医学中心证据等级和Modified Downs and Black清单由两名评价者独立评估证据水平和偏倚风险。
  • 局限:作者指出因研究设计局限、高偏倚风险及方法学/结局异质性,无法得出确定结论。
  • 局限:作者指出需要前瞻性纵向研究以进一步了解慢性吞咽障碍对健康和生活质量的影响。

对床旁实践的改变

  • 作者认为当前数据提示危重症成人吞咽障碍患病率高,且可持续≥12个月出院后。
  • 作者指出鉴于隐性误吸发生率高,需要前瞻性纵向研究进一步了解慢性吞咽障碍对健康和生活质量的影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To determine the prevalence and characteristics of oropharyngeal dysphagia in critically ill adults during acute and postacute care settings.

DATA SOURCES: This systematic review was registered on PROSPERO and used Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Five electronic databases were searched (PubMed, Scopus, Cochrane Library, CINAHL, and Embase) from the time of inception to September 2024 using search terms: dysphagia, deglutition disorders, swallowing disorders, sepsis, postintensive care syndrome, COVID-19, critical illness.

STUDY SELECTION: Independent review of articles was conducted by two raters using four inclusion criteria: 1) adults older than 18 years; 2) diagnosis of COVID-19, sepsis, critical illness, or ostintensive care syndrome and dysphagia; 3) underwent clinical swallow evaluation; and 4) in acute or postacute care setting.

DATA EXTRACTION: Two raters independently assessed levels of research evidence and risk of bias using the Oxford center for Evidence-based Medicine Levels of Evidence and the Modified Downs and Black Checklist and extracted demographics, study design, dysphagia assessment methods, outcomes, and comorbidities.

DATA SYNTHESIS: After removing duplicates, 5058 articles were identified and 4844 screened out based on title/abstract. Full-text review was completed for 214 articles, and 51 met inclusion. Prevalence of dysphagia ranged from 15% to 100%. Dysphagia persisted in up to 74% of individuals at hospital discharge and up to 22% of patients 10 to 17 months posthospital discharge.

CONCLUSIONS: Due to study design limitations, high risk of bias, and heterogeneity in methods/outcomes, firm conclusions cannot be drawn. However, current data suggest a high prevalence of dysphagia in critically ill adults who persists greater than or equal to 12 months posthospital discharge. Given the high rates of silent aspiration, prospective, longitudinal research is needed to further understand the prevalence and impact of chronic dysphagia on health and quality of life in critically ill adults.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Donohue C, Raye K, Pandharipande P, et al. A Systematic Review of the Prevalence and Characteristics of Oropharyngeal Dysphagia in Critically Ill Patients During the Acute and Postacute Recovery Phase. Crit Care Med. 2025. PMID: 40145810. doi:10.1097/CCM.0000000000006669

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。